Utama › Kanser Paru-paru Bukan Sel Kecil › Minnesota › Saint Paul
Kajian klinikal Kanser Paru-paru Bukan Sel Kecil di Saint Paul, MN
18 kajian untuk Kanser Paru-paru Bukan Sel Kecil sedang mencari peserta di lokasi dalam dan sekitar Saint Paul (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Mengambil pesertaFasa 3
- Regions Hospital, Saint Paul
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 2
- Health Partners Cancer Center at Regions Hospital, Saint Paul
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Mengambil pesertaFasa 3
- Regions Hospital, Saint Paul
- United Hospital, Saint Paul
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Mengambil pesertaFasa 3
- Allina Health Cancer Institute - United Hospital, Saint Paul
- Minnesota Oncology Hematology, P.A., Maplewood · 5 mi jauh
- Minnesota Oncology Hematology, PA, Woodbury · 7 mi jauh
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Mengambil pesertaFasa 3
- Allina Health Cancer Institute - United Hospital, Saint Paul
- Minnesota Oncology Hematology, P.A., Maplewood · 5 mi jauh
- Minnesota Oncology Hematology, P.A., Woodbury · 7 mi jauh
- dan 1 lagi
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Mengambil pesertaFasa 3
- Regions Hospital, Saint Paul
- M Health Fairview St. John's Hospital, Maplewood · 5 mi jauh
- Minnesota Oncology Hematology PA, Maplewood · 5 mi jauh
- dan 1 lagi
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Mengambil pesertaFasa 2
- Regions Hospital, Saint Paul
- United Hospital, Saint Paul
- Minnesota Oncology Hematology PA-Maplewood, Maplewood · 5 mi jauh
- dan 3 lagi
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Mengambil pesertaFasa 3
- Clinical Study Site, Saint Paul
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Mengambil pesertaFasa 3
- HealthPartners Cancer Research Center, Saint Paul
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Mengambil pesertaFasa 3
- Research Site, Saint Paul
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Mengambil pesertaFasa 1/2
- USOR Minnesota Oncology Hematology, Maplewood · 5 mi jauh
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
Mengambil pesertaFasa 1/2
- Health Partners Cancer Center at Regions Hospital, Saint Paul
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
Mengambil pesertaFasa 1/2
- HealthPartners Cancer Center at Regions Hospital, Saint Paul
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Mengambil pesertaFasa 1
- Allina Health Cancer Institute - United Hospital, Saint Paul
- Allina Health Cancer Institute, Saint Paul
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2
- Regions Hospital, Saint Paul
- United Hospital, Saint Paul
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2/3
- Regions Hospital, Saint Paul
- United Hospital, Saint Paul
- Minnesota Oncology Hematology PA-Woodbury, Woodbury · 7 mi jauh
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Mengambil pesertaKajian pemerhatian
- Regions Hospital, Saint Paul
- United Hospital, Saint Paul
- Minnesota Oncology Hematology PA-Maplewood, Maplewood · 5 mi jauh
- dan 3 lagi
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- Research Site 121, Saint Paul
Kajian Kanser Paru-paru Bukan Sel Kecil di bandar lain
- Houston, TX145 kajian
- New York City, NY120 kajian
- Arlington, VA104 kajian
- Nashville, TN97 kajian
- Boston, MA90 kajian
- Los Angeles, CA87 kajian
- St. Louis, MO73 kajian
- Chicago, IL61 kajian
- Baltimore, MD60 kajian
- San Antonio, TX59 kajian
- Columbus, OH56 kajian
- Washington, DC55 kajian
Kajian lain di Saint Paul
- Kanser Paru-paru13 kajian
- Kanser Prostat13 kajian
- Kanser Payudara12 kajian
- Kanser Kolorektal9 kajian
- Kanser Ovari8 kajian
- Kanser Metastatik7 kajian
- Kanser Ginjal (Karsinoma Sel Renal)7 kajian
- Kanser Endometrium6 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher6 kajian
- Melanoma6 kajian
- Leukemia Mieloid Akut6 kajian
- Obesiti6 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.